Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Fleshner

Showing results (81-90 of 292) with videos related to

Pageof 30
Sort By:
Cancer|December 24, 2003
Is there age bias in the treatment of localized prostate carcinoma?Shabbir M H Alibhai, Murray D Krahn, Marsha M Cohen, et al.
European Urology|December 13, 2025
Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177Giorgio Gandaglia, Alberto Briganti, James W Catto, et al.
Sexual Medicine Reviews|March 21, 2026
On-demand testosterone for the treatment of female sexual dysfunction: a systematic reviewLeyi B Yin, Rui M Bernardino, Keiran Pace, et al.
The Journal of Urology|May 16, 2006
Population based survival data on urachal tumorsJehonathan H Pinthus, Riad Haddad, John Trachtenberg, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic modelVasundara Venkateswaran, Laurence H Klotz, Meera Ramani, et al.
Plos Medicine|September 28, 2007
Optimal management of high-risk T1G3 bladder cancer: a decision analysisGirish S Kulkarni, Antonio Finelli, Neil E Fleshner, et al.
Lancet (London, England)|January 27, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialNeil E Fleshner, M Scott Lucia, Blair Egerdie, et al.
Journal of Clinical Medicine|September 9, 2023
Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate CancerAmanjot Sidhu, Nabeeha Khan, Cameron Phillips, et al.
The Journal of Urology|July 21, 2010
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 menShabbir M H Alibhai, Minh Duong-Hua, Angela M Cheung, et al.
Clinical Epigenetics|March 29, 2019
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progressionShivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, et al.
Pageof 30

Showing results (81-90 of 292) with videos related to

Sort By:
Pageof 30
Cancer|December 24, 2003
Is there age bias in the treatment of localized prostate carcinoma?Shabbir M H Alibhai, Murray D Krahn, Marsha M Cohen, et al.
European Urology|December 13, 2025
Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177Giorgio Gandaglia, Alberto Briganti, James W Catto, et al.
Sexual Medicine Reviews|March 21, 2026
On-demand testosterone for the treatment of female sexual dysfunction: a systematic reviewLeyi B Yin, Rui M Bernardino, Keiran Pace, et al.
The Journal of Urology|May 16, 2006
Population based survival data on urachal tumorsJehonathan H Pinthus, Riad Haddad, John Trachtenberg, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic modelVasundara Venkateswaran, Laurence H Klotz, Meera Ramani, et al.
Plos Medicine|September 28, 2007
Optimal management of high-risk T1G3 bladder cancer: a decision analysisGirish S Kulkarni, Antonio Finelli, Neil E Fleshner, et al.
Lancet (London, England)|January 27, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialNeil E Fleshner, M Scott Lucia, Blair Egerdie, et al.
Journal of Clinical Medicine|September 9, 2023
Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate CancerAmanjot Sidhu, Nabeeha Khan, Cameron Phillips, et al.
The Journal of Urology|July 21, 2010
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 menShabbir M H Alibhai, Minh Duong-Hua, Angela M Cheung, et al.
Clinical Epigenetics|March 29, 2019
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progressionShivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, et al.
Pageof 30